MarginsXMarginsX
Home › Markets › FEED

ENvue Medical, Inc. (FEED)

FEED is quoted over the counter, not listed on an exchange. ENvue Medical, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.2500
-33.9% on the day
1-year return
-99.5%
Market cap
$231K
Nano cap. From the Nov 16, 2026 close × 924K shares (10-Q cover page, Aug 17, 2026)
P/E and P/S
Net loss over the period · 0.1×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerFEED, quoted over the counter
SEC CIK0001326706
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codeOrthopedic, Prosthetic & Surgical Appliances & Supplies
Business addressTyler, TX
Incorporated inDE

Warning signs

Cash runway
1.1 months
$1.1M cash at June 30, 2026
Share count, 1 year
+1290.9%
2025-08-19 to 2026-08-17 · +73249.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 17, 2026
Insider net buying, 12 months
-$151K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern for twelve months from the date of issuance of these interim condensed consolidated financial statements."
10-Q 2026-08-17
Cash and burn$1.1M cash; operating cash flow -$2.9M a quarter.Report 2026-06-30
Shares outstanding923,718 (2026-08-17); 796,950 a year earlier; 1,662,330 three years earlier. 3y figure adjusted for splits (1-for-110 overall).Cover page 2026-08-17
Reverse splits, 3 years3; latest 1-for-12 on 2026-09-01Source 2026-09-01
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-08-10
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-07-10
AuditorKost Forer Gabbay & Kasierer, Tel Aviv, Israel; changed auditors 1 time in 24 months8-K 4.01 2025-08-14
Late filings, 12 months3 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $0, sold $151K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$239K-$4.9M-$2.7M$1.1M$2.2M$1.9M10-Q 2026-08-17
Q1 2026
2026-03-31
$653K-$3.8M-$4.3M$2.2M$2.2M$2.2M10-Q 2026-05-18
Q4 2025
2025-12-31
$312K-$12.9M-$2.7M$4.2M$2.2M$2.6M10-K 2026-04-15
Q3 2025
2025-09-30
$722K$510K-$2.0M$7.0M$2.1M$2.7M10-Q 2025-11-14
Q2 2025
2025-06-30
$494K-$4.0M-$3.4M$4.0M$2.0M$2.3M10-Q 2026-08-17
Q1 2025
2025-03-31
$1.0M-$1.9M-$1.3M$571K$1.3M$2.7M10-Q 2026-05-18
Q4 2024
2024-12-31
$444K-$1.4M-$548K$752K$2.3M$2.6M10-K 2026-04-15
Q3 2024
2024-09-30
$376K-$998K-$836K$1.3MNo debt tags$3.3M10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-08-10
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-08-17
Latest current report8-K2026-10-14
Latest proxyDEF 14A2026-07-24

Source: SEC EDGAR submissions feed, 551 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier